Advocating prudent D-dimer testing: constructive perspectives and comments on 'How we manage a high D-dimer'.
作者信息
Gonzaga Yung, De Alencar José Nunes
机构信息
Hematology. Instituto Nacional de Cancer. Rio de Janeiro - RJ; Hematology. Grupo Oncoclínicas. Rio de Janeiro - RJ.
Cardiology. Instituto Dante Pazzanese de Cardiologia. São Paulo - SP.
出版信息
Haematologica. 2024 Oct 1;109(10):3452-3453. doi: 10.3324/haematol.2024.285691.
Abstract
摘要
相似文献
1
Advocating prudent D-dimer testing: constructive perspectives and comments on 'How we manage a high D-dimer'.倡导谨慎的D-二聚体检测：对《我们如何处理高D-二聚体》的建设性观点与评论
Haematologica. 2024 Oct 1;109(10):3452-3453. doi: 10.3324/haematol.2024.285691.
2
Response to the Comment: "Advocating prudent D-dimer testing: constructive perspectives and comments on "How we manage a high D-dimer".对评论的回应：“倡导谨慎的D-二聚体检测：对‘我们如何处理高D-二聚体’的建设性观点与评论”
Haematologica. 2024 Oct 1;109(10):3454. doi: 10.3324/haematol.2024.285769.
3
Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.对D-二聚体和高分子量纤维蛋白降解产物具有同等特异性的单克隆抗体。
Blood Coagul Fibrinolysis. 2016 Jul;27(5):542-50. doi: 10.1097/MBC.0000000000000453.
4
A comparative evaluation of ELISAs for D-dimer and related fibrin(ogen) degradation products.D - 二聚体及相关纤维蛋白（原）降解产物酶联免疫吸附测定法的比较评估
Blood Coagul Fibrinolysis. 1993 Aug;4(4):537-49. doi: 10.1097/00001721-199308000-00003.
5
Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.血浆D-二聚体水平与纤维蛋白原/纤维蛋白降解产物（FDP）之间的关联用于排除血栓栓塞性疾病。
J Thromb Thrombolysis. 2006 Apr;21(2):199-202. doi: 10.1007/s11239-006-4837-9.
6
[Analysis of D-dimer laboratory findings and clinical evaluation].[D-二聚体实验室检查结果分析与临床评估]
Orv Hetil. 2017 Dec;158(50):1971-1976. doi: 10.1556/650.2017.30909.
7
Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.特定纤维蛋白（原）降解产物与静脉血栓栓塞症相关的诊断可能性
Blood Coagul Fibrinolysis. 2013 Apr;24(3):297-304. doi: 10.1097/MBC.0b013e32835bdcbd.
8
Comments on point of care D-dimer testing in the emergency department: a bioequivalence study.急诊科即时检测D-二聚体的评论：一项生物等效性研究。
Ann Lab Med. 2014 Jan;34(1):64-5. doi: 10.3343/alm.2014.34.1.64. Epub 2013 Dec 6.
9
C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?斯皮德韦尔研究中C反应蛋白、纤维蛋白D-二聚体与缺血性心脏病发病：炎症与纤维蛋白周转在发病机制中有关联吗？
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):603-10. doi: 10.1161/01.atv.21.4.603.
10
High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.高纤维蛋白/纤维蛋白原降解产物与纤维蛋白原比值与严重创伤患者的28天死亡率及大量输血相关。
Eur J Trauma Emerg Surg. 2018 Apr;44(2):291-298. doi: 10.1007/s00068-017-0844-0. Epub 2017 Sep 18.
本文引用的文献
1
The Post Hoc Pitfall: Rethinking Sensitivity and Specificity in Clinical Practice.事后归因的陷阱：重新审视临床实践中的敏感性和特异性
J Gen Intern Med. 2024 Jun;39(8):1506-1510. doi: 10.1007/s11606-024-08692-z. Epub 2024 Feb 27.
2
How we manage a high D-dimer.如何管理高 D-二聚体。
Haematologica. 2024 Apr 1;109(4):1035-1045. doi: 10.3324/haematol.2023.283966.
3
Systemic Lupus Erythematosus.系统性红斑狼疮。
Ann Intern Med. 2020 Jun 2;172(11):ITC81-ITC96. doi: 10.7326/AITC202006020.
4
The D-dimer assay.D-二聚体检测。
Am J Hematol. 2019 Jul;94(7):833-839. doi: 10.1002/ajh.25482. Epub 2019 Apr 19.
5
Troponin Testing for Clinicians.肌钙蛋白检测在临床中的应用
J Am Coll Cardiol. 2016 Nov 29;68(21):2365-2375. doi: 10.1016/j.jacc.2016.08.066.
6
Understanding diagnostic tests 1: sensitivity, specificity and predictive values.理解诊断测试1：敏感性、特异性和预测值。
Acta Paediatr. 2007 Mar;96(3):338-41. doi: 10.1111/j.1651-2227.2006.00180.x.
7
Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice.理解诊断测试2：似然比、检验前概率和检验后概率及其在临床实践中的应用。
Acta Paediatr. 2007 Apr;96(4):487-91. doi: 10.1111/j.1651-2227.2006.00179.x. Epub 2007 Feb 14.
Zotero 插件